UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 29, 2008
CryoCor, Inc.
(Exact name of registrant as specified in its charter)
| Delaware |
000-51410 |
33-0922667 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
| 9717 Pacific Heights Boulevard San Diego, California |
92121 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (858) 909-2200
Not Applicable.
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02. | Results of Operations and Financial Condition. |
On April 29, 2008, we announced the amounts of our cash, cash equivalents and investments as well as total debt outstanding under our senior debt facility as of certain dates in the “Recommendation – Background of Offer” section of Item 4 of a Solicitation/Recommendation Statement on Schedule 14D-9 filed by us with the Securities and Exchange Commission (the “SEC”), which is attached hereto as Exhibit 99.1 and incorporated herein by reference.
The information in this Item 2.02 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits. |
| 99.1 | Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on April 29, 2008.(1) | |
| (1) | Incorporated by reference to our Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on April 29, 2008. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CryoCor, Inc. | ||
| By: | /s/ Gregory J. Tibbitts | |
| Gregory J. Tibbitts | ||
| Vice President, Finance and Chief Financial Officer (Principal Financial and Accounting Officer) | ||
Date: April 29, 2008
INDEX TO EXHIBITS
| 99.1 | Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on April 29, 2008.(1) | |
| (1) | Incorporated by reference to our Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on April 29, 2008. |